Ceragon Networks Ltd. remains a Buy due to robust backlog, growing demand in India and North America, and appealing valuation despite execution risks. CRNT's backlog hit record highs, with $120M in Indian orders and strong North American Tier-1 carrier progress, but margin pressures persist. Management lowered 2024 margin guidance, citing supply-chain and mix headwinds, yet maintained 2026 revenue outlook and expects earnings recovery by 2027.
Ceragon Networks NASDAQ: CRNT reported second-quarter 2026 revenue of $93.9 million, up 14.2% from $82.3 million a year earlier, as demand in India and North America supported growth. The company said bookings reached their highest level since the first quarter of 2024, while first-half bookings and book-to-bill represented its strongest first half in 10 years.
After reaching a new 52-week high in early June, shares of wireless backhaul solutions provider Ceragon Networks have given back most of their year-to-date gains in recent weeks. While the company continues to see strong demand for its products, Q2 results will be materially impacted by a semiconductor supply chain issue. In addition, management pointed to margin pressures from component and raw material cost inflation as well as higher freight costs.
Ceragon Networks Ltd. (CRNT) Q1 2026 Earnings Call Transcript
Ceragon Networks NASDAQ: CRNT reported first-quarter 2026 revenue of $85 million and non-GAAP earnings of $0.01 per diluted share, describing the period as a “solid start” marked by strong execution in India and continued activity in North America.
Ceragon Networks (CRNT) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.03 per share a year ago.
Ceragon Networks: Upgrading On Improved Outlook And Discounted Valuation
Ceragon Networks: Why I See Compelling Upside From Here
Ceragon Networks Ltd. (CRNT) Q4 2025 Earnings Call Transcript
Ceragon Networks (CRNT) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.09 per share a year ago.
RXO, CRNT and PYPL have been added to the Zacks Rank #5 (Strong Sell) List on February 12, 2026.
Ceragon (CRNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.